This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Segarra, G. Articles by Pelligrino, D. A. Search for Related Content PubMed PubMed Citation Articles by Segarra, G. Articles by Pelligrino, D. A. Related Collections Cardio-renal physiology/pathophysiology Endothelium/vascular type/nitric oxide Brain Circulation and Metabolism

(Stroke. 1999;30:2206-2211.)
© 1999 American Heart Association, Inc.

Original Contributions

Effects of Some Guanidino Compounds on Human Cerebral Arteries

G. Segarra, BSc; P. Medina, PhD; R. M. Ballester, BSc; P. Lluch, MD; M. Aldasoro, MD; J. M. Vila, PhD S. Lluch, MD

From the Departments of Physiology (G.S., P.M., R.M.B., M.A., J.M.V., S.L.) and Medicine (P.L.), University of Valencia, 46010, Valencia, Spain.

Correspondence to S. Lluch, MD, Departamento de Fisiología, Facultad de Medicina y Odontología, Blasco Ibáñez, 17, 46010 Valencia, Spain. E-mail medinap{at}post.uv.es

Background and Purpose—Accumulation of endogenous guanidino-substituted analogues of L-arginine in chronic renal failure might contribute to some of the vascular and neurological disorders of this pathology. We tested the hypothesis that in human cerebral arteries, some guanidino compounds may increase vascular tone, through nitric oxide (NO) synthase inhibition, and impair endothelium-dependent relaxation.

Methods—Rings of human middle cerebral artery were obtained during autopsy of 26 patients who had died 3 to 12 hours before. The rings were suspended in organ baths for isometric recording of tension. We then studied the responses to N^G-monomethyl-L-arginine (L-NMMA), N^G,N^G-dimethyl-L-arginine (asymmetrical dimethylarginine; ADMA), aminoguanidine (AG), and methylguanidine (MG).

Results—L-NMMA (10^-6 to 3x10^-4 mol/L) and ADMA (10^-6 to 3x10^-4 mol/L) caused concentration- and endothelium-dependent contractions (median effective concentrations [EC₅₀]=1.1x10^-5 and 1.6x10^-5 mol/L, respectively; E_max=35.5±7.9% and 43.9±5.9% of the response to 100 mmol/L KCl). AG (10^-5 to 3x10^-3 mol/L) and MG (10^-5 to 3x10^-3 mol/L) produced endothelium-independent contractions (E_max=44.3±8.8% and 45.7±5.8% of the response to 100 mmol/L KCl, respectively). L-Arginine (10^-3 mol/L) prevented the contractions by L-NMMA and ADMA but did not change contractions induced by AG and MG. L-NMMA and ADMA inhibited endothelium-dependent relaxation induced by acetylcholine in a concentration-dependent manner; AG and MG were without effect.

Conclusions—The results suggest that the contractions induced by L-NMMA and ADMA are due to inhibition of endothelial NO synthase activity, whereas AG and MG do not affect the synthesis of NO. An increase in the plasma concentration of L-NMMA and ADMA associated with uremia is likely to represent a diminished release or effect of NO, and consequently, an increased cerebrovascular tone in uremic patients is highly conceivable.

Editorial Comment

Dale A. Pelligrino, PhD, Guest Editor

Neuroanesthesiology Research Laboratory, University of Illinois at Chicago, Chicago, Illinois

This article has been cited by other articles:

				H. Dayoub, R. N. Rodionov, C. Lynch, J. P. Cooke, E. Arning, T. Bottiglieri, S. R. Lentz, and F. M. Faraci Overexpression of Dimethylarginine Dimethylaminohydrolase Inhibits Asymmetric Dimethylarginine-Induced Endothelial Dysfunction in the Cerebral Circulation Stroke, January 1, 2008; 39(1): 180 - 184. [Abstract] [Full Text] [PDF]

				J. T. Kielstein, F. Donnerstag, S. Gasper, J. Menne, A. Kielstein, J. Martens-Lobenhoffer, F. Scalera, J. P. Cooke, D. Fliser, and S. M. Bode-Boger ADMA Increases Arterial Stiffness and Decreases Cerebral Blood Flow in Humans Stroke, August 1, 2006; 37(8): 2024 - 2029. [Abstract] [Full Text] [PDF]

				P. Lluch, M. D. Mauricio, J. M. Vila, G. Segarra, P. Medina, J. A. del Olmo, J. M. Rodrigo, and M. A. Serra Accumulation of Symmetric Dimethylarginine in Hepatorenal Syndrome Experimental Biology and Medicine, January 1, 2006; 231(1): 70 - 75. [Abstract] [Full Text] [PDF]

				R. H. Boger Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Explains the "L-Arginine Paradox" and Acts as a Novel Cardiovascular Risk Factor J. Nutr., October 1, 2004; 134(10): 2842S - 2847S. [Abstract] [Full Text] [PDF]

				R. H Boger The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor Cardiovasc Res, October 1, 2003; 59(4): 824 - 833. [Abstract] [Full Text] [PDF]

				R. Maas, E. Schwedhelm, J. Albsmeier, and R. H Boger The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function Vascular Medicine, August 1, 2002; 7(3): 213 - 225. [Abstract] [PDF]

				M. C. Stuhlinger, F. Abbasi, J. W. Chu, C. Lamendola, T. L. McLaughlin, J. P. Cooke, G. M. Reaven, and P. S. Tsao Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor JAMA, March 20, 2002; 287(11): 1420 - 1426. [Abstract] [Full Text] [PDF]

				J. T. Kielstein, J. C. Frolich, H. Haller, and D. Fliser ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease? Nephrol. Dial. Transplant., September 1, 2001; 16(9): 1742 - 1745. [Full Text] [PDF]

				G. Segarra, P. Medina, J. M. Vila, J. B. Martinez-Leon, R. M. Ballester, P. Lluch, and S. Lluch Contractile effects of arginine analogues on human internal thoracic and radial arteries J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 729 - 736. [Abstract] [Full Text] [PDF]